Response Rates in Hidradenitis Suppurativa Continue to Climb With New Therapies

(MedPage Today) -- NEW ORLEANS -- A trio of novel therapies produced clinically significant improvements in 40% to 70% of patients with moderate to severe hidradenitis suppurativa (HS), according to data reported here. Izokibep, a novel interleukin...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news